Meeting of the National Vaccine Advisory Committee, 2910 [2011-868]

Download as PDF mstockstill on DSKH9S0YB1PROD with NOTICES 2910 Federal Register / Vol. 76, No. 11 / Tuesday, January 18, 2011 / Notices means and instrumentalities for the commission of deceptive acts and practices, and accordingly, themselves committed a deceptive act in violation of Section 5 of the FTC Act. The Commission also alleges that by stating that the NGBA and the NAGC endorsed Tested Green, respondents represented expressly or impliedly that they were independent from these organizations, when, in fact, they own and operate NGBA and NAGC. Therefore, respondents’ statement of endorsement by NGBA and NAGC was false and misleading, in violation of Section 5. Similarly, in light of respondents’ express and implied representation that these organizations were independent, respondents’ failure to disclose their relationship to NGBA and NAGC was deceptive, in violation of Section 5. Part I of the proposed order prohibits respondents from misrepresenting: (1) The fact that, or degree to which, they have, or a third party has, evaluated a product, package, service, practice, or program based on its environmental benefits or attributes; (2) that respondents have, or a third party has, the appropriate expertise to evaluate the environmental benefits or attributes of a product, package, service, practice, or program; (3) the number of certifications issued by respondents; and (4) that a product, package, certification, service, practice, or program is endorsed by an independent person or organization. Part II of the proposed order bars respondents, in connection with the labeling, advertising, marketing, promotion, offering for sale, sale, or distribution of any product, package, certification, service, practice, or program, from providing others with the means and instrumentalities to make, expressly or impliedly, any false or misleading statement. Part III of the proposed order bars respondents from making any representation, expressly or by implication, about any user or endorser of a product, package, certification, service, practice, or program, unless they clearly and prominently disclose a material connection with such user or endorser, where one exists. Parts IV through VIII of the proposed order are reporting and compliance provisions. Part IV requires respondents to retain documents relating to their compliance with the order. Part V requires dissemination of the order to all current and future principals, officers, directors, managers, employees, agents, and representatives having responsibilities relating to the subject matter of the order. Part VI ensures notification to the FTC of changes in VerDate Mar<15>2010 16:24 Jan 14, 2011 Jkt 223001 respondent Nonprofit Management’s corporate status. Part VII mandates that respondent Claeys notify the FTC of any changes in his business affiliations or employment. Part VIII mandates that respondents submit a report to the Commission detailing their compliance with the order. Part IX provides that the order expires after twenty (20) years, with certain exceptions. The purpose of this analysis is to aid public comment on the proposed order. It is not intended to constitute an official interpretation of the proposed order or to modify its terms in any way. By direction of the Commission. Donald S. Clark, Secretary. [FR Doc. 2011–926 Filed 1–14–11; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice of meeting. AGENCY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (DHHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting. The meeting is open to the public. Preregistration is required for both public attendance and comment. Individuals who wish to attend the meeting and/or participate in the public comment session should either e-mail nvpo@hhs.gov or call 202–690–5566 to register and provide name, organization, and e-mail address. DATES: The meeting will be held on February 16, 2011 from 8:30 a.m. to 5 p.m., EDT, and February 17, 2011 from 8:30 am to 4 p.m., EDT. ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey Building, Room 800, 200 Independence Avenue, SW., Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, Department of Health and Human Services, Room 715–H, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201. Phone: (202) 690–5566; Fax: (202) 260– 1165; e-mail: nvpo@hhs.gov. SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. 300aa–1), the SUMMARY: PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The National Vaccine Advisory Committee was established to provide advice and make recommendations to the Director of the National Vaccine Program on matters related to the program’s responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program. Topics to be discussed at the meeting include the National Vaccine Plan, Influenza 2010–2011 Season, H1N1 Vaccine Safety, and other related issues. The meeting agenda will be posted on the Web site: https://www.hhs.gov/nvpo/ nvac at least one week prior to the meeting. Public attendance at the meeting is limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the National Vaccine Program Office at the address/phone listed above at least one week prior to the meeting. Members of the public will have the opportunity to provide comments at the meeting. Public comment will be limited to five minutes per speaker. Individuals who would like to submit written statements should e-mail or fax their comments to the National Vaccine Program Office at least five business days prior to the meeting. Dated: January 7, 2011. Bruce Gellin, Deputy Assistant Secretary for Health, Director, National Vaccine Program Office. [FR Doc. 2011–868 Filed 1–14–11; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES HIT Policy Committee’s Meaningful Use Workgroup Meetings; Notice of Meetings and Request for Comments Office of the National Coordinator for Health Information Technology, HHS. ACTION: Notice of Meetings and request for comments. AGENCY: This notice announces the forthcoming subcommittee meetings of a Federal advisory committee of the Office of the National Coordinator for Health Information Technology (ONC). The meeting will be open to the public. Name of Subcommittee: HIT Policy Committee Meaningful Use Workgroup. E:\FR\FM\18JAN1.SGM 18JAN1

Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 76, Number 11 (Tuesday, January 18, 2011)]
[Notices]
[Page 2910]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-868]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (DHHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a 
meeting. The meeting is open to the public. Pre-registration is 
required for both public attendance and comment. Individuals who wish 
to attend the meeting and/or participate in the public comment session 
should either e-mail nvpo@hhs.gov or call 202-690-5566 to register and 
provide name, organization, and e-mail address.

DATES: The meeting will be held on February 16, 2011 from 8:30 a.m. to 
5 p.m., EDT, and February 17, 2011 from 8:30 am to 4 p.m., EDT.

ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey 
Building, Room 800, 200 Independence Avenue, SW., Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, 
Department of Health and Human Services, Room 715-H, Hubert H. Humphrey 
Building, 200 Independence Avenue, SW., Washington, DC 20201. Phone: 
(202) 690-5566; Fax: (202) 260-1165; e-mail: nvpo@hhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The National Vaccine Advisory Committee was 
established to provide advice and make recommendations to the Director 
of the National Vaccine Program on matters related to the program's 
responsibilities. The Assistant Secretary for Health serves as Director 
of the National Vaccine Program.
    Topics to be discussed at the meeting include the National Vaccine 
Plan, Influenza 2010-2011 Season, H1N1 Vaccine Safety, and other 
related issues. The meeting agenda will be posted on the Web site: 
https://www.hhs.gov/nvpo/nvac at least one week prior to the meeting. 
Public attendance at the meeting is limited to space available. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the National Vaccine Program Office at the address/phone listed 
above at least one week prior to the meeting. Members of the public 
will have the opportunity to provide comments at the meeting. Public 
comment will be limited to five minutes per speaker. Individuals who 
would like to submit written statements should e-mail or fax their 
comments to the National Vaccine Program Office at least five business 
days prior to the meeting.

    Dated: January 7, 2011.
Bruce Gellin,
Deputy Assistant Secretary for Health, Director, National Vaccine 
Program Office.
[FR Doc. 2011-868 Filed 1-14-11; 8:45 am]
BILLING CODE 4150-44-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.